Gyre Therapeutics Inc.

NASDAQ: GYRE · Real-Time Price · USD
8.02
-0.20 (-2.43%)
At close: Aug 15, 2025, 12:02 PM

Gyre Therapeutics Revenue

Gyre Therapeutics reported an annual revenue of $105.76M, reflecting a -6.78% growth. For the quarter ending June 30, 2025, Gyre Therapeutics generated $26.77M in revenue.
Revenue (ttm)
105.76M
Revenue Growth
-6.78%
Price / Sales Ratio
9.74
Revenue / Employee
182.65K
Employees
579
Market Cap
727.89M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.